“Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 4-Year Analysis of the KEEPsAKE 1 and 2 Trials” (2024) SKIN The Journal of Cutaneous Medicine, 8(6), p. s444. doi:10.25251/skin.8.supp.444.